48,170 Shares in Tempus AI, Inc. (NASDAQ:TEM) Purchased by Captrust Financial Advisors

Captrust Financial Advisors purchased a new position in Tempus AI, Inc. (NASDAQ:TEM - Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 48,170 shares of the company's stock, valued at approximately $2,726,000.

Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. Sumitomo Mitsui Trust Group Inc. boosted its position in shares of Tempus AI by 1,591.2% in the third quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,217,699 shares of the company's stock worth $68,922,000 after buying an additional 1,145,698 shares during the period. Sigma Planning Corp acquired a new stake in Tempus AI during the 3rd quarter worth about $1,323,000. Dakota Wealth Management acquired a new stake in Tempus AI during the 3rd quarter worth about $1,185,000. Davidson Kempner Capital Management LP purchased a new position in Tempus AI during the 2nd quarter valued at about $2,271,000. Finally, NEA Management Company LLC acquired a new position in shares of Tempus AI in the 2nd quarter valued at about $160,048,000.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on TEM shares. Bank of America downgraded Tempus AI from a "buy" rating to a "neutral" rating and raised their price target for the stock from $45.00 to $60.00 in a research note on Wednesday, October 2nd. JPMorgan Chase & Co. upped their target price on Tempus AI from $42.00 to $47.00 and gave the company an "overweight" rating in a research note on Wednesday, August 7th. Stifel Nicolaus lowered shares of Tempus AI from a "buy" rating to a "hold" rating and increased their price target for the stock from $45.00 to $65.00 in a research report on Monday, November 11th. Needham & Company LLC reaffirmed a "buy" rating and set a $47.00 price objective on shares of Tempus AI in a research note on Wednesday, August 7th. Finally, Loop Capital boosted their target price on Tempus AI from $48.00 to $57.00 and gave the stock a "buy" rating in a report on Tuesday, October 15th. Three investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $54.22.

Tempus AI Stock Down 6.4 %

Shares of Tempus AI stock traded down $3.71 on Thursday, hitting $54.28. The company had a trading volume of 1,296,576 shares, compared to its average volume of 1,198,376. The company has a 50-day simple moving average of $53.58. The company has a quick ratio of 2.55, a current ratio of 2.69 and a debt-to-equity ratio of 8.17. Tempus AI, Inc. has a twelve month low of $22.89 and a twelve month high of $79.49.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.